Literature DB >> 21643890

Baseline immune phenotypes and CD4+ T lymphocyte responses to antiretroviral therapy in younger versus older HIV-infected individuals.

Risa M Hoffman1, Beth D Jamieson, Ronald J Bosch, Judith Currier, Christina M R Kitchen, Ingrid Schmid, Yuda Zhu, Kara Bennett, Ronald Mitsuyasu.   

Abstract

OBJECTIVE: The purpose of the study was to determine associations between pre-antiretroviral therapy (ART) senescent CD8+ T lymphocytes and naïve versus non-naive CD8+ and CD4+ T lymphocyte subpopulations and CD4+ responses after initiation of ART in younger versus older individuals.
METHODS: Retrospective analysis of 100 subjects with pre-ART cryopreserved peripheral blood mononuclear cells samples was performed with flow cytometry. Subjects were divided into four groups by age (30-50 years or > 50 years) and 96-week CD4+ response (<100 or >200 cells/mm(3)). All subjects had 96-week viral suppression to <50 copies/mm(3). Regression was utilized to investigate associations between pre-ART CD8+ and CD4+ T cell phenotypes with age and CD4+ response categories.
RESULTS: Individuals <50 years had a lower frequency of senescent CD8+ T lymphocytes of the CD56 + 57+, CD56+, and CD28- phenotypes (95%CI -3.6 to -0.02; 95%CI -4.2 to -0.03; 95%CI -12.5 to -1.4, respectively) and a higher frequency of naïve (CD45RA + CD28+) CD8+ T lymphocytes (95%CI 2.6 to 10.9). Younger age and good CD4+ response were associated with a higher frequency of pre-ART naïve CD4+ T cells (95%CI 2.0 to 16.4 and 95%CI 1.5 to 15.6, respectively).
CONCLUSIONS: Prior to ART, younger HIV-infected individuals have a higher frequency of naïve CD4+ and CD8+ T cells and lower frequency of senescent CD8+ T cell phenotypes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21643890      PMCID: PMC3194061          DOI: 10.1007/s10875-011-9550-6

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  37 in total

1.  The immune risk phenotype is associated with IL-6 in the terminal decline stage: findings from the Swedish NONA immune longitudinal study of very late life functioning.

Authors:  Anders Wikby; Bengt-Olof Nilsson; Rosalyn Forsey; Julie Thompson; Jan Strindhall; Sture Löfgren; Jan Ernerudh; Graham Pawelec; Frederick Ferguson; Boo Johansson
Journal:  Mech Ageing Dev       Date:  2006-06-05       Impact factor: 5.432

2.  Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002.

Authors:  F Bonnet; R Thiébaut; G Chêne; D Neau; J-L Pellegrin; P Mercié; J Beylot; F Dabis; R Salamon; P Morlat
Journal:  HIV Med       Date:  2005-05       Impact factor: 3.180

3.  No Immune Risk Profile among individuals who reach 100 years of age: findings from the Swedish NONA immune longitudinal study.

Authors:  Jan Strindhall; Bengt-Olof Nilsson; Sture Löfgren; Jan Ernerudh; Graham Pawelec; Boo Johansson; Anders Wikby
Journal:  Exp Gerontol       Date:  2007-05-21       Impact factor: 4.032

4.  Changes in CD8 and CD4 lymphocyte subsets, T cell proliferation responses and non-survival in the very old: the Swedish longitudinal OCTO-immune study.

Authors:  A Wikby; P Maxson; J Olsson; B Johansson; F G Ferguson
Journal:  Mech Ageing Dev       Date:  1998-05-15       Impact factor: 5.432

5.  Effects of HIV-1 infection on lymphocyte phenotypes in blood versus lymph nodes.

Authors:  Otto O Yang; John J Ferbas; Mary Ann Hausner; Lance E Hultin; Patricia M Hultin; David McFadden; Mark Sawicki; Roger Detels; Martin Majchrowicz; Jose L Matud; Janis V Giorgi; Beth D Jamieson
Journal:  J Acquir Immune Defic Syndr       Date:  2005-08-15       Impact factor: 3.731

6.  Dysregulation of CD28 and CTLA-4 expression by CD4 T cells from previously immunodeficient HIV-infected patients with sustained virological responses to highly active antiretroviral therapy.

Authors:  S F Stone; P Price; M A French
Journal:  HIV Med       Date:  2005-07       Impact factor: 3.180

7.  Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly.

Authors:  Sine Reker Hadrup; Jan Strindhall; Tania Køllgaard; Tina Seremet; Boo Johansson; Graham Pawelec; Per thor Straten; Anders Wikby
Journal:  J Immunol       Date:  2006-02-15       Impact factor: 5.422

8.  An immune risk phenotype, cognitive impairment, and survival in very late life: impact of allostatic load in Swedish octogenarian and nonagenarian humans.

Authors:  Anders Wikby; Frederick Ferguson; Rosalyn Forsey; Julie Thompson; Jan Strindhall; Sture Löfgren; Bengt-Olof Nilsson; Jan Ernerudh; Graham Pawelec; Boo Johansson
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2005-05       Impact factor: 6.053

9.  Immune reconstitution after 2 years of successful potent antiretroviral therapy in previously untreated human immunodeficiency virus type 1-infected adults.

Authors:  D W Notermans; N G Pakker; D Hamann; N A Foudraine; R H Kauffmann; P L Meenhorst; J Goudsmit; M T Roos; P T Schellekens; F Miedema; S A Danner
Journal:  J Infect Dis       Date:  1999-10       Impact factor: 5.226

10.  Clinical outcome of HIV-infected patients with sustained virologic response to antiretroviral therapy: long-term follow-up of a multicenter cohort.

Authors:  Félix Gutierrez; Sergio Padilla; Mar Masiá; José A Iribarren; Santiago Moreno; Pompeyo Viciana; Leopoldo Muñoz; José L Gómez Sirvent; Francesc Vidal; José López-Aldeguer; José R Blanco; Manuel Leal; María Angeles Rodríguez-Arenas; Santiago Perez Hoyos
Journal:  PLoS One       Date:  2006-12-20       Impact factor: 3.240

View more
  5 in total

1.  Substance Abuse, Hepatitis C, and Aging in HIV: Common Cofactors that Contribute to Neurobehavioral Disturbances.

Authors:  Randi Melissa Schuster; Raul Gonzalez
Journal:  Neurobehav HIV Med       Date:  2012-02-16

Review 2.  Sex, age, race and intervention type in clinical studies of HIV cure: a systematic review.

Authors:  Rowena E Johnston; Mary M Heitzeg
Journal:  AIDS Res Hum Retroviruses       Date:  2015-01       Impact factor: 2.205

3.  Purging Exhausted Virus-Specific CD8 T Cell Phenotypes by Somatic Cell Reprogramming.

Authors:  Joshua Chan; Patrick Y Kim; Emiko Kranz; Yoshiko Nagaoka; YooJin Lee; Jing Wen; Heidi J Elsaesser; Meng Qin; David G Brooks; Gene-Errol Ringpis; Irvin S Y Chen; Masakazu Kamata
Journal:  AIDS Res Hum Retroviruses       Date:  2017-11       Impact factor: 2.205

4.  Factors related to changes in CD4+ T-cell counts over time in patients living with HIV/AIDS: a multilevel analysis.

Authors:  Ulisses Ramos Montarroyos; Demócrito Barros Miranda-Filho; Cibele Comini César; Wayner Vieira Souza; Heloisa Ramos Lacerda; Maria de Fátima Pessoa Militão Albuquerque; Mariana Freitas Aguiar; Ricardo Arraes de Alencar Ximenes
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

5.  Establishment of Normal Reference Intervals for CD3(+), CD4(+), CD8(+), and CD4(+) to CD8(+) Ratio of T Lymphocytes in HIV Negative Adults from University of Gondar Hospital, North West Ethiopia.

Authors:  Addisu Gize; Biniam Mathewos; Beyene Moges; Meseret Workineh; Lealem Gedefaw
Journal:  AIDS Res Treat       Date:  2014-11-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.